Benchmark indices nosedived nearly a percent, suffering the biggest fall since September 27. Sensex lost 360 points to settle at 33371 while Nifty finished at 10350, down 102 points. BSE mid-cap and small-cap indices tumbled 1.5% and 1.4% respectively.
Except 2.1% and 1.2% higher IT and Teck indices respectively, all the BSE sectoral indices ended in red with Healthcare index leading the tally, down 3.5%, followed by 2.2% lower Realty index. Lupin collapsed 16.9%, becoming top Nifty loser, followed by 7.1% lower Cipla. HCL Tech and HPCL were the top gainers, up 3.8% and 3% respectively. BSE advance-decline ratio stood at 1:2.2.
Rupee was trading at 65.02/$, depreciating 35 paise compared to previous close.
Lupin share nosedived after company's formulation manufacturing facilities at Goa and Indore (Pithampur Unit II) received warning letter from USFDA.
Cipla reported better-than-expected consolidated profit growth of 17.7% at Rs 435 cr. Revenue rose 8.8% to Rs 4082 cr. EBITDA grew by 18.2% to Rs 804 crore and margin expanded 160 basis points to 19.7%.
BHEL reported lower-than-expected 5.9% y-o-y rise in net profit at Rs 115.4 cr driven by other income of Rs 485 cr. Revenue fell 5.8% to Rs 6168 cr. On EBIDTA level, company reported a loss Rs 95 cr.
European markets were trading mixed with modest changes
US stock futures were suggesting a flattish start.
Tracking pessimistic global cues, Indian indices edged lower at start. Benchmarks extended southward journey amid weakness in Asian markets. Sensex shed over 150 points and Nifty closed at 5831. On sectorial front, FMCG was the top laggard dragged by HUL and ITC.
Nifty futures/Bank Nifty futures market closed on 8444.60 / 18340. According to technical analysis if Nifty futures and Bank Nifty future moves up-word in tomorrow treading session then 8528 will be small resistance for Nifty futures and at the same time 18534 will be small Resistance for Bank Nifty futures,
Benchmark indices nosedived nearly a percent, suffering the biggest fall since September 27. Sensex lost 360 points to settle at 33371 while Nifty finished at 10350, down 102 points. BSE mid-cap and small-cap indices tumbled 1.5% and 1.4% respectively.
Except 2.1% and 1.2% higher IT and Teck indices respectively, all the BSE sectoral indices ended in red with Healthcare index leading the tally, down 3.5%, followed by 2.2% lower Realty index. Lupin collapsed 16.9%, becoming top Nifty loser, followed by 7.1% lower Cipla. HCL Tech and HPCL were the top gainers, up 3.8% and 3% respectively. BSE advance-decline ratio stood at 1:2.2.
Rupee was trading at 65.02/$, depreciating 35 paise compared to previous close.
Lupin share nosedived after company's formulation manufacturing facilities at Goa and Indore (Pithampur Unit II) received warning letter from USFDA.
Cipla reported better-than-expected consolidated profit growth of 17.7% at Rs 435 cr. Revenue rose 8.8% to Rs 4082 cr. EBITDA grew by 18.2% to Rs 804 crore and margin expanded 160 basis points to 19.7%.
BHEL reported lower-than-expected 5.9% y-o-y rise in net profit at Rs 115.4 cr driven by other income of Rs 485 cr. Revenue fell 5.8% to Rs 6168 cr. On EBIDTA level, company reported a loss Rs 95 cr.
European markets were trading mixed with modest changes
US stock futures were suggesting a flattish start.
Tracking pessimistic global cues, Indian indices edged lower at start. Benchmarks extended southward journey amid weakness in Asian markets. Sensex shed over 150 points and Nifty closed at 5831. On sectorial front, FMCG was the top laggard dragged by HUL and ITC.
Nifty futures/Bank Nifty futures market closed on 8444.60 / 18340. According to technical analysis if Nifty futures and Bank Nifty future moves up-word in tomorrow treading session then 8528 will be small resistance for Nifty futures and at the same time 18534 will be small Resistance for Bank Nifty futures,
India PR Wire Jan 7, 2009 Markets Plummet As Investors Panic After Satyam Sho...Jagannadham Thunuguntla
“Satyam has indeed dented investor and business confidence with this new revelation,” said Jagannadham Thunuguntla, head of the capital markets arm and director of India's fourth largest share brokerage firm, the Delhi-based SMC Group.
We provide you around 1-2 nifty tips, Bank Nifty Future, nifty futures tips, sgx nifty tips Daily. You can gain more profit with our 2 days free trial calls.
India PR Wire Jan 7, 2009 Markets Plummet As Investors Panic After Satyam Sho...Jagannadham Thunuguntla
“Satyam has indeed dented investor and business confidence with this new revelation,” said Jagannadham Thunuguntla, head of the capital markets arm and director of India's fourth largest share brokerage firm, the Delhi-based SMC Group.
We provide you around 1-2 nifty tips, Bank Nifty Future, nifty futures tips, sgx nifty tips Daily. You can gain more profit with our 2 days free trial calls.
We provide you around 1-2 nifty tips, Bank Nifty Future, nifty futures tips, sgx nifty tips Daily. You can gain more profit with our 2 days free trial calls.
We provide you around 1-2 nifty calls, Bank Nifty Future, nifty futures tips, sgx nifty tips Daily. You can gain more profit with our 2 days free trial calls.
2. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.
Daily Equity Report
INDIAN MARKET
INDIAN FACE
INDIAN EQUITY BENCHMARK continued their winning streak
for the fourth consecutive session after (SBI) managed to
stem rise in bad loans in its fiscal third quarter and reported
30% increase in net profit for the December ended quarter.
Max India rose 3.22% after net profit spurted 346.8% to
Rs329.33 crore on 40.9% growth in total income to Rs416.44
crore in Q3 December 2014 over Q3 December 2013.
SpiceJet fell 2%, after the company reported a net loss of
Rs275.03 crore in Q3 December 2014, higher than net loss of
Rs172.80 crore in Q3 December 2013.
GLOBAL FACE
Asian shares gained on news of a ceasefire accord in Ukraine,
while Sweden's surprise moves to cut its main rate into
negative territory and hopes of a resolution between debt-
strapped Greece and its creditors burnished risk appetite.
European shares rose in early trading with robust growth
figures from Germany sending the country's blue-chip DAX
index to a record high.
US stock futures poised for a higher opening at the Wall Street
on Friday.
INDICES CLOSE PREVIOUS
SENSEX 29094.93 28805.10
NIFTY 8805.50 8711.55
ASIAN MARKET
INDICES CLOSE PREVIOUS
NIKKEI 17,913.36 17,979.72
HANG SENG 24,682.54 24,422.15
KOSPI 1,957.50 1,941.63
SECTORIAL INDICES
INDICES CLOSE CHANGE (%)
CNX 100 8,800.20 0.98
S&P CNX 500 7176.20 0.96
CNX MIDCAP 13,100.80 0.81
CNX 200 4,544.20 0.99
BANK NIFTY 19369.70 1.26
TOP GAINERS
SCRIPT CLOSE CHANGE (%)
SBIN 307.70 8.23
M&M 1,191.05 4.99
LUPIN 1677.00 3.67
JINDALSTEL 151.60 3.30
TOP LOSERS
SCRIPT CLOSE CHANGE (%)
GAIL 405.45 -4.07
BHEL 259.40 -3.10
DLF 155.25 -2.20
ONGC 339.50 -2.01
3. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.
Daily Equity Report
MARKET MOVERS UPSIDE NIFTY SPOT
TREND STRATEGY
BULLISH BUY ON DIPS
PIVOT POINTS
S3 S2 S1 P R1 R2 R3
8600 8693 8749 8785 8841 8878 8970
NIFTY
SUPPORT RESISTANCE
S1-8795 R1-8925
S2-8750 R2-8965
BANK NIFTY FUTURE
TREND STRATEGY
BULLISH BUY ON DIPS
PIVOT POINTS
S3 S2 S1 P R1 R2 R3
18771 19048 19208 19324 19485 19601 19878
BANK NIFTY
SUPPORT RESISTANCE
S1-19150 R1-19580
S2-18995 R2-19750
SCRIPT CLOSE
CHANGE
(%)
TCS 2538.75 3.11
ITC 378.05 2.07
RELIANCE 917.50 0.92
COAL INDIA 377.85 2.47
MARKET MOVERS DOWNSIDE
SCRIPT CLOSE
CHANGE
(%)
ONGC 339.55 [1.99]
HDFC BNK 1065.80 [0.95]
INFOSYS 2296.10 [0.65]
TECHM 2886.55 [0.78]
FII & DII ACTIVITY
INSTITUTION
NET BUY
(CR.)
NET SELL
(CR)
FII 4589.36 4199.10
DII 2454.14 2358.32
NSE TOTALS
INDICES ADVANCES DECLINES
NIFTY 42 8
BANK NIFTY 9 3
4. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.
Daily Equity Report
r
MARKET TALKS
Positive for cash-strapped Suzlon (diversification, though thru
personal capacity, by Sun Pharma promoters would be
sentimentally negative for Sun Pharma).
Thomas Cook arm signs definitive
agreement to acquire Aramark
Thomas Cook (India) announced that its subsidiary, Quess Group
has signed definitive agreement to acquire Aramark India from
Aramark, subject to regulatory approvals. Based out of Mumbai,
Aramark India is a facility management company offering niche
offerings in hospitality and healthcare facility management. This
acquisition will strengthen Quess's position as a leading Pan
India.
Cipla to form a JV company in
Algeria
Cipla (EU) will hold a 40% stake in the JV company while the
remainder will be held by a Biopharm-led Algerian consortium.
The JV company is expected to make an investment of up to
USD 15 million in the construction of a manufacturing facility.
Cipla (EU)'s initial investment in cash in the JV company is
expected to be $ 6 million.
Lupin surges after RBI allows to raise
FII limit
The Reserve Bank of India after market hours yesterday, February 12,
2015, announced hike in the ceiling on investment in shares of Lupin
by foreign institutional investors ( FIIs)/Registered Foreign Portfolios
Investors ( RFPIs) under the portfolio investment scheme to 49% of
the company's equity capital with effect from February 12, 2015, from
earlier 33%.
ICICI Pru Life looking at selling 5%
stake
ICICI Pru Life looking at selling 5% stake with company valuation of
US $6 billion (Rs37,000-37,500 crore) – Positive for ICICI Bank
(sentimentally though upside to life insurance value does has less
than 5% impact on target price); more positive for Max India and Bajaj
Finserv (life insurance forms over 60-85% of valuations).
Promoters of Sun Pharma may buy
stake in Suzlon
Suzlon – Promoters of Sun Pharma could take stake in Suzlon
The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any
responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most.
Use of this report in no way constitutes a client/advisor relationship, all information we communicate to you (the subscriber) either through
our Web site or other forms of communications, are purely for informational purposes only. We recommend seeking individual investment
advice before making any investment, for you are assuming sole liability for your investments. Capital Stars will in no way have discretionary
authority over your trading or investment accounts.
All rights reserved.
DISCLAIMER